FoxO3a phosphorylation

There are 7 papers on FoxO3a phosphorylation in aging research: none in people yet, 6 in animals, 1 in cells.

Biomarker

7 papers study it3 more mention it3 findings

See all 10 papers on FoxO3a phosphorylation

  • Animals6
  • Cells1

Interventions

2

Canagliflozin

downin mice1

1 study
  1. Canagliflozin decreases FoxO3a phosphorylation in mice.

    “declines in primordial follicles FoxO3a phosphorylation, a marker of activation, when compared to the age-matched controls”

    Animalsprimordial follicleschronicfemales

    Canagliflozin treatment prevents follicular exhaustion and attenuates hallmarks of ovarian aging in genetically heterogenous mice

    GeroScience

More on Canagliflozin

Syringaresinol

downin mice1

1 study
  1. Syringaresinol decreases FoxO3a phosphorylation in Sod1-/- (SOD1-deficient) mice.

    “Syringaresinol also decreased the oxidative damage and the phosphorylation of FoxO3a protein”

    Animalsin Sod1-/- (SOD1-deficient) miceskin

    Syringaresinol Reverses Age-Related Skin Atrophy by Suppressing FoxO3a-Mediated Matrix Metalloproteinase-2 Activation in Copper/Zinc Superoxide Dismutase-Deficient Mice

    The Journal of investigative dermatology

More on Syringaresinol

Upstream

1

NF-κB signaling

upin human cells1

1 study
  1. NF-κB signaling increases FoxO3a phosphorylation in human cells under exogenous inflammatory stimulation.

    “NF-κB signalling inhibited osteogenesis by promoting FOXO3a phosphorylation and increasing c-JUN expression”

    Cellsunder exogenous inflammatory stimulation

    Inflammation Affects the Osteogenic Differentiation of Aged Periodontal Ligament Cells via NF-κB/FOXO3a/c-JUN Signalling

    Journal of periodontal research

More on NF-κB signaling

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months